Regeneron Pharmaceuticals, Inc. - Common Stock — Dividend History & Yield (NASDAQ:REGN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends Documents

Dividends per share —————— 3.64 Dividend yield % —————— — Payout ratio % —————— 39.38

News

Regeneron Says Newly Approved Drug Shows Sustained Efficacy In Halting Rogue Bone Growth

Regeneron Pharmaceuticals Announces Data From Its Phase 3 OPTIMA Study Of Pasatru To Treat Fibrodysplasia Ossificans Progressiva Shows Efficacy In Stopping New Bone Growth; Trial Meets Primary Endpoint By Reducing 90% New Heterotopic Ossification Lesions

Will Regeneron (REGN) Beat Estimates Again in Its Next Earnings Report?

Why Regeneron (REGN) is a Top Value Stock for the Long-Term

Bayer Seeks Kerendia Label Expansion in Non-Diabetic CKD

RBC Capital Maintains Sector Perform on Regeneron Pharmaceuticals, Raises Price Target to $810

Stocks Settle Lower on Higher Bond Yields

Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $780

Stocks Fall and Bond Yields Rise on Inflation Worries

Morgan Stanley Maintains Equal-Weight on Regeneron Pharmaceuticals, Raises Price Target to $779

Genmab: Epkinly Shines In Phase 3 DLBCL Trial (NASDAQ:GMAB)

JP Morgan Maintains Overweight on Regeneron Pharmaceuticals, Raises Price Target to $950